BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22436259)

  • 1. Considerations on causality in pharmacovigilance.
    Edwards IR
    Int J Risk Saf Med; 2012; 24(1):41-54. PubMed ID: 22436259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria.
    Shakir SA; Layton D
    Drug Saf; 2002; 25(6):467-71. PubMed ID: 12071785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance.
    Perrio M; Voss S; Shakir SA
    Drug Saf; 2007; 30(4):333-46. PubMed ID: 17408310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological evidence in forensic pharmacovigilance.
    Persaud N; Healy D
    Int J Risk Saf Med; 2012; 24(1):31-5. PubMed ID: 22436257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance.
    Théophile H; André M; Arimone Y; Haramburu F; Miremont-Salamé G; Bégaud B
    J Clin Epidemiol; 2012 Oct; 65(10):1069-77. PubMed ID: 22910538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conditional maximized sequential probability ratio test for pharmacovigilance.
    Li L; Kulldorff M
    Stat Med; 2010 Jan; 29(2):284-95. PubMed ID: 19941282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.
    Goldman SA
    Food Drug Law J; 2007; 62(3):513-28. PubMed ID: 17915393
    [No Abstract]   [Full Text] [Related]  

  • 8. A new method for assessing drug causation provided agreement with experts' judgment.
    Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Molimard M; Moore N; Haramburu F
    J Clin Epidemiol; 2006 Mar; 59(3):308-14. PubMed ID: 16488362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causality in Pharmacoepidemiology and Pharmacovigilance: a theoretical excursion.
    Mota DM; Kuchenbecker RS
    Rev Bras Epidemiol; 2017; 20(3):475-486. PubMed ID: 29160439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing causality in the assessment of safety of medicines for children.
    Ashby D
    Acta Paediatr; 2008 Dec; 97(12):1611-6. PubMed ID: 18793295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance in Europe and North America: divergent approaches.
    Wiktorowicz M; Lexchin J; Moscou K
    Soc Sci Med; 2012 Jul; 75(1):165-70. PubMed ID: 22521677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Causality in urologic research].
    Carrasco Asenjo M
    Arch Esp Urol; 2003; 56(6):577-88. PubMed ID: 12958992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forensic pharmacovigilance and substandard or counterfeit drugs.
    Labadie J
    Int J Risk Saf Med; 2012; 24(1):37-9. PubMed ID: 22436258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A weight of evidence approach to causal inference.
    Swaen G; van Amelsvoort L
    J Clin Epidemiol; 2009 Mar; 62(3):270-7. PubMed ID: 18834711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological causality.
    Morabia A
    Hist Philos Life Sci; 2005; 27(3-4):365-79. PubMed ID: 16898206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causation and causal inference in epidemiology.
    Rothman KJ; Greenland S
    Am J Public Health; 2005; 95 Suppl 1():S144-50. PubMed ID: 16030331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The French pharmacovigilance system: structure and missions].
    Welsch M; Alt M; Richard MH; Imbs JL
    Presse Med; 2000 Jan; 29(2):102-6. PubMed ID: 10682040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
    Hauben M; Reich L; Gerrits CM
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Popper and the problem of induction in epidemiology].
    Banegas JR; Rodríguez Artalejo F; del Rey Calero J
    Rev Esp Salud Publica; 2000; 74(4):327-39. PubMed ID: 11031841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.